resource-symbol

Eczema Area and Severity Index (EASI)

Hanifin J.M.; Thurston M.; Omoto M.; Cherill R.; Tofte S.J.; Graeber M.; EASI Evaluator Group

Distributed by Mapi Research Trust

Distributed by Mapi Research Trust

default distrib
 

Basic description

Developed in 2001 from the Psoriasis Area and Severity Index (PASI). The individual components of EASI (i.e. body region involvement, severity) can be separated and evaluated independently or in combination

Authors

Hanifin J.M.; Thurston M.; Omoto M.; Cherill R.; Tofte S.J.; Graeber M.; EASI Evaluator Group

Copyright
Instrument controlled by Wiley
Objective
To assess the extent and severity of atopic dermatitis (AD) or eczema at 4 body sites (Head/neck, Trunk, Upper extremities and Lower extremities) and measure 4 clinical signs, Erythema, Inuration/Papulation, Excoriation and Lichenification, in a simple, effective, comprehensive, consistent, and flexible way for a range of patients
Therapeutic area
  • Skin and Connective Tissue Diseases
  • Immune System Diseases
  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Therapeutic indication
  • Eczema
  • Dermatitis, Atopic
Type of Clinical Outcome Assessment (COA)
  • ClinRO ClinRO
Original language(s)
  • English for the USA
Bibliographic reference(s) of the original questionnaire

Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol. 2001 Feb;10(1):11-8 (PubMed Abstract)


Contact and conditions of use

Authors

Hanifin J.M.; Thurston M.; Omoto M.; Cherill R.; Tofte S.J.; Graeber M.; EASI Evaluator Group

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Licensing for the original version

The use of the original version of the questionnaire is licensed by Wiley.

A license agreement must be completed beforehand and a user fee is required to all users (commercial and academic users).

Please contact: permissions@wiley.com

Distribution of Translations

Existing translations can be obtained from Mapi Research Trust:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the Request for Translations form, or any other document to your online request. Click the link below for the Request for Translations form
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Access fees

ROYALTY FEES* Commercial users Cost per study See above, under "Licensing for the original version"
Cost per language See above, under "Licensing for the original version"
Funded academic research Cost per study See above, under "Licensing for the original version"
Cost per language See above, under "Licensing for the original version"
Not funded academic users Cost per study See above, under "Licensing for the original version"
Cost per language See above, under "Licensing for the original version"
DISTRIBUTION FEES* Commercial users Cost per study Free
Cost per language 750 Euros
Funded academic research Cost per study Free
Cost per language 100 Euros
Not funded academic users Cost per study Free
Cost per language Free

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

These fees are Mapi Research Trust fees

Languages

Original language(s)

  • English for the USA

Translations

The translations listed may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

EASI

Czech for Czech Republic*
Danish for Denmark*
Dutch for Belgium (Flemish)*
Dutch for the Netherlands*
English for the UK*
French for Belgium*
French for France*
Greek for Greece*
Italian for Italy*
Japanese for Japan*
Korean for South Korea*
Polish for Poland*
Russian for Russia*
Slovak for Slovakia*
Spanish for Spain*
Swedish for Sweden*
* Performed by Mapi

The author has selected Mapi as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.

For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).

Conditions to translate

Commercial Users

Exclusive vendor for translation work for commercial users: Mapi

More information on translations

To obtain existing translations of the EASI, please submit a request

Note: A per-translation fee is requested

Last update: October 2017
For additional information, please submit a request. More information in our FAQs.

YOU MIGHT ALSO BE INTERESTED IN:

PROLABELS symbol PROLABELS: 1 indication